Overview
Randall Hughes is an Oncologist in Dallas, Texas. Dr. Hughes is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Endoscopy.
His clinical research consists of co-authoring 27 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2201 Inwood Rd, Dallas, TX 75235
6202 Harry Hines Blvd, Dallas, TX 75390
Additional Areas of Focus
Dr. Hughes has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Texas Southwestern Medical Center
John Minna is an Oncologist in Dallas, Texas. Dr. Minna is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
Texas Oncology, P.A.
Dr. Konduri attended medical school at the University College of Medical Sciences-India. He then completed a residency in Internal Medicine at Rush Presbyterian St Luke's - Westlake Residency Program, Melrose Park, Illinois, followed by a fellowship in Medical Oncology at Baylor University Medical Center, part of Baylor Scott & White Health. Dr. Konduri is certified in Internal Medicine and in Medical Oncology by the American Board of Internal Medicine. He specializes in medical oncology with a particular interest in lung and thoracic oncology. Dr. Konduri is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer.
Office
David Gerber is an Oncologist in Dallas, Texas. Dr. Gerber is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Endoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Hughes isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Hughes isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Hughes isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Hughes isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Hughes isDistinguished. Learn about Lung Cancer.
- Nasopharyngeal CarcinomaDr. Hughes isDistinguished. Learn about Nasopharyngeal Carcinoma.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Hughes isAdvanced. Learn about Adenoid Cystic Carcinoma.
- Anaplastic Thyroid CancerDr. Hughes isAdvanced. Learn about Anaplastic Thyroid Cancer.
- Bone TumorDr. Hughes isAdvanced. Learn about Bone Tumor.
- Epithelial-Myoepithelial Carcinoma
- Ewing SarcomaDr. Hughes isAdvanced. Learn about Ewing Sarcoma.
- Experienced
- Adrenal CancerDr. Hughes isExperienced. Learn about Adrenal Cancer.
- Adult Soft Tissue SarcomaDr. Hughes isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Hughes isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Hughes isExperienced. Learn about Alveolar Soft Part Sarcoma.
- AstrocytomaDr. Hughes isExperienced. Learn about Astrocytoma.
- Ataxia-Pancytopenia SyndromeDr. Hughes isExperienced. Learn about Ataxia-Pancytopenia Syndrome.